576 related articles for article (PubMed ID: 23026601)
1. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
[TBL] [Abstract][Full Text] [Related]
2. Posttransplantation calcineurin inhibitor-induced hemolytic uremic syndrome: single-center experience.
Said T; Al-Otaibi T; Al-Wahaib S; Francis I; Nair MP; Halim MA; El-Sayed A; Nampoory MR
Transplant Proc; 2010 Apr; 42(3):814-6. PubMed ID: 20430179
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic microangiopathy after kidney transplantation.
Ponticelli C; Banfi G
Transpl Int; 2006 Oct; 19(10):789-94. PubMed ID: 16961769
[TBL] [Abstract][Full Text] [Related]
4. Postrenal transplant hemolytic uremic syndrome/thrombotic microangiopathy: Ahmedabad experience.
Goplani KR; Vanikar AV; Shah PR; Gumber M; Feroz A; Patel HV; Kasat P; Falodia J; Saboo D; Kaswaan K; Geerish MS; Pandya T; Trivedi HL
Transplant Proc; 2008 May; 40(4):1114-6. PubMed ID: 18555127
[TBL] [Abstract][Full Text] [Related]
5. De novo thrombotic microangiopathy in renal transplant recipients: a comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy.
Schwimmer J; Nadasdy TA; Spitalnik PF; Kaplan KL; Zand MS
Am J Kidney Dis; 2003 Feb; 41(2):471-9. PubMed ID: 12552512
[TBL] [Abstract][Full Text] [Related]
6. Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy.
Bren A; Pajek J; Grego K; Buturovic J; Ponikvar R; Lindic J; Knap B; Vizjak A; Ferluga D; Kandus A
Transplant Proc; 2005 May; 37(4):1889-91. PubMed ID: 15919494
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.
Wiener Y; Nakhleh RE; Lee MW; Escobar FS; Venkat KK; Kupin WL; Mozes MF
Clin Transplant; 1997 Jun; 11(3):157-62. PubMed ID: 9193835
[TBL] [Abstract][Full Text] [Related]
8. [Thrombotic microangiopathy after kidney transplantation].
Basić-Jukić N; Jurić I; Brunetta-Gavranić B; Kes P; Bubić-Filipi L; Glavas-Boras S
Acta Med Croatica; 2008; 62 Suppl 1():93-6. PubMed ID: 18578340
[TBL] [Abstract][Full Text] [Related]
9. Consequences of hemolytic uremic syndrome among hemodialysis patients.
Brunelli SM; Claxton A; Mehta S; Anum EA
J Nephrol; 2015 Jun; 28(3):361-7. PubMed ID: 25491936
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
Cutler C; Henry NL; Magee C; Li S; Kim HT; Alyea E; Ho V; Lee SJ; Soiffer R; Antin JH
Biol Blood Marrow Transplant; 2005 Jul; 11(7):551-7. PubMed ID: 15983555
[TBL] [Abstract][Full Text] [Related]
11. Everolimus, cyclosporine, and thrombotic microangiopathy: clinical role and preventive tools in renal transplantation.
Nava F; Cappelli G; Mori G; Granito M; Magnoni G; Botta C; Solazzo A; Fontana F; Baisi A; Bonucchi D
Transplant Proc; 2014 Sep; 46(7):2263-8. PubMed ID: 25242766
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
Clark WF
Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic microangiopathy in United States long-term dialysis patients.
Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
[TBL] [Abstract][Full Text] [Related]
14. Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections.
Artz MA; Steenbergen EJ; Hoitsma AJ; Monnens LA; Wetzels JF
Transplantation; 2003 Sep; 76(5):821-6. PubMed ID: 14501861
[TBL] [Abstract][Full Text] [Related]
15. Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients.
Koppula S; Yost SE; Sussman A; Bracamonte ER; Kaplan B
Clin Transplant; 2013; 27(4):591-7. PubMed ID: 23923969
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of hemolytic uremic syndrome after liver-kidney transplantation.
Gatti S; Arru M; Reggiani P; Como G; Rossi F; Fassati LR; Ponticelli C
J Nephrol; 2003; 16(4):586-90. PubMed ID: 14696763
[TBL] [Abstract][Full Text] [Related]
17. Clinical profile and outcomes of
Saikumar Doradla LP; Lal H; Kaul A; Bhaduaria D; Jain M; Prasad N; Thammishetti V; Gupta A; Patel M; Sharma RK
Saudi J Kidney Dis Transpl; 2020; 31(1):160-168. PubMed ID: 32129209
[TBL] [Abstract][Full Text] [Related]
18. Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report.
Chandran S; Baxter-Lowe L; Olson JL; Tomlanovich SJ; Webber A
Transplant Proc; 2011 Jun; 43(5):2097-101. PubMed ID: 21693335
[TBL] [Abstract][Full Text] [Related]
19. [Hemolytic-uremic syndrome following kidney transplantation: prognostic factors].
Candinas D; Keusch G; Schlumpf R; Burger HR; Gmür J; Largiadèr F
Schweiz Med Wochenschr; 1994 Oct; 124(41):1789-99. PubMed ID: 7973505
[TBL] [Abstract][Full Text] [Related]
20. Analyses of data of patients with Thrombotic Microangiopathy in the WAA registry.
Mörtzell M; Berlin G; Nilsson T; Axelsson CG; Efvergren M; Audzijoni J; Griskevicius A; Ptak J; Blaha M; Tomsova H; Liumbruno GM; Centoni P; Newman E; Eloot S; Dhondt A; Tomaz J; Witt V; Rock G; Stegmayr B
Transfus Apher Sci; 2011 Oct; 45(2):125-31. PubMed ID: 21903476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]